MiRNA-210: A Current Overview.

microRNAs (miRNAs) are a group of highly conserved small non-coding RNAs that were found to enhance mRNA degradation or inhibit post-transcriptional translation. Accumulating evidence indicates that miRNAs contribute to tumorigenesis and cancer metastasis. microRNA-210 has been largely studied in the past several years and has been identified as a major miRNA induced under hypoxia. A variety of miR-210 targets have been identified pointing to its role, not only in mitochondrial metabolism, but also in angiogenesis, the DNA damage response, cell proliferation, and apoptosis. Based on earlier research findings, this review aims to provide a current overview on the involvement of miRNA-210 in biological processes and diseases.

[1]  Supriyo Chakraborty,et al.  Interplay between miRNAs and human diseases , 2018, Journal of cellular physiology.

[2]  N. Wang,et al.  Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[3]  Y. Liu,et al.  Circulating miR‐210 as a diagnostic and prognostic biomarker for colorectal cancer , 2017, European journal of cancer care.

[4]  Yu Dai,et al.  Three-layered polyplex as a microRNA targeted delivery system for breast cancer gene therapy , 2017, Nanotechnology.

[5]  K. Inamura.  Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer , 2017, Cells.

[6]  N. Mottet,et al.  Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma. , 2017, Urologic oncology.

[7]  J. Hung,et al.  Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1 , 2017, Oncogene.

[8]  N. H. Nagoor,et al.  Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1’S-1’-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4 , 2017, Molecules and cells.

[9]  J. Canon,et al.  The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer , 2017, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  W. Blalock,et al.  RNA processing and ribosome biogenesis in bone marrow failure dsorders , 2017 .

[11]  K. Jażdżewski,et al.  Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy , 2017, Oncotarget.

[12]  R. Giffard,et al.  Distinct Effects of miR-210 Reduction on Neurogenesis: Increased Neuronal Survival of Inflammation But Reduced Proliferation Associated with Mitochondrial Enhancement , 2017, The Journal of Neuroscience.

[13]  Yanlong Xiao,et al.  Protection of Human Umbilical Vein Endothelial Cells against Oxidative Stress by MicroRNA-210 , 2017, Oxidative medicine and cellular longevity.

[14]  Q. Mai,et al.  MicroRNA‐210 is increased and it is required for dedifferentiation of osteosarcoma cell line , 2017, Cell biology international.

[15]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[16]  Matthew D Disney,et al.  Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit. , 2017, Journal of the American Chemical Society.

[17]  T. Ochiya,et al.  Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review , 2017, International Journal of Clinical Oncology.

[18]  Q. Ding,et al.  Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure , 2017, Oncotarget.

[19]  H. Yoshino,et al.  microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma , 2017, Oncotarget.

[20]  J. Rodrigo,et al.  Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation , 2017, Oncotarget.

[21]  S. Salahuddin,et al.  Relationship between hypoxia and downstream pathogenic pathways in preeclampsia , 2017, Hypertension in pregnancy.

[22]  M. Matboli,et al.  Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia. , 2017, Gene.

[23]  Hyewon Youn,et al.  Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells , 2016, Oncotarget.

[24]  Yuan Yang,et al.  MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. , 2016, Oncology reports.

[25]  F. Sun,et al.  The functional and predictive roles of miR-210 in cryptorchidism , 2016, Scientific Reports.

[26]  Licheng Chen,et al.  Involvement of upregulation of miR-210 in a rat epilepsy model , 2016, Neuropsychiatric disease and treatment.

[27]  D. Ye,et al.  MicroRNA-210 and its theranostic potential , 2016, Expert opinion on therapeutic targets.

[28]  S. Fucharoen,et al.  Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients , 2016, International Journal of Hematology.

[29]  Rich Hartman,et al.  Inhibition of microRNA-210 provides neuroprotection in hypoxic–ischemic brain injury in neonatal rats , 2016, Neurobiology of Disease.

[30]  C. Lawrie,et al.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies , 2016, International journal of molecular sciences.

[31]  D. Iliopoulos,et al.  Neurotensin Promotes the Development of Colitis and Intestinal Angiogenesis via Hif-1α–miR-210 Signaling , 2016, The Journal of Immunology.

[32]  B. S. Sørensen,et al.  Hypoxia-regulated MicroRNAs in Gastroesophageal Cancer. , 2016, Anticancer research.

[33]  Yangyu Zhao,et al.  Hypoxia-inducible miR-210 contributes to preeclampsia via targeting thrombospondin type I domain containing 7A , 2016, Scientific Reports.

[34]  M. O’Connell,et al.  New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins , 2015, Biomolecules.

[35]  Keman Liao,et al.  MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells. , 2015, Folia neuropathologica.

[36]  Guixi Zheng,et al.  Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer , 2015, PloS one.

[37]  J. Zuo,et al.  MiR‐210 Links Hypoxia With Cell Proliferation Regulation in Human Laryngocarcinoma Cancer , 2015, Journal of cellular biochemistry.

[38]  L. Myatt,et al.  Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity , 2015, International Journal of Obesity.

[39]  Kyvan Dang,et al.  The Role of Hypoxia-Induced miR-210 in Cancer Progression , 2015, International journal of molecular sciences.

[40]  Lu Ding,et al.  miR-210, a modulator of hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cell. , 2015, International journal of clinical and experimental medicine.

[41]  Sha Li,et al.  Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..

[42]  Mario Acunzo,et al.  MicroRNA and cancer--a brief overview. , 2015, Advances in biological regulation.

[43]  L. Cocco,et al.  Emerging role for PLCβ1 MiRNA and disease , 2014 .

[44]  S. Greco,et al.  HypoxamiR regulation and function in ischemic cardiovascular diseases. , 2014, Antioxidants & redox signaling.

[45]  Frank J. Slack,et al.  Aberrant Regulation and Function of MicroRNAs in Cancer , 2014, Current Biology.

[46]  W. Blalock,et al.  Identification of the PKR Nuclear Interactome Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell Division , 2014, Journal of cellular physiology.

[47]  Wei Yang,et al.  Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance. , 2014, Experimental cell research.

[48]  C. A. Pereira,et al.  MicroRNAs Discriminate Familial from Sporadic Non-BRCA1/2 Breast Carcinoma Arising in Patients ≤35 Years , 2014, PloS one.

[49]  Multiple functions of hypoxia-regulated miR-210 in cancer , 2014, Journal of experimental & clinical cancer research : CR.

[50]  Ke Huang,et al.  Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis. , 2014, International journal of oncology.

[51]  J. McCubrey,et al.  PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells , 2014, Oncotarget.

[52]  Zeng-li Miao,et al.  MicroRNA-210 overexpression predicts poorer prognosis in glioma patients , 2014, Journal of Clinical Neuroscience.

[53]  Shuai Zhang,et al.  Differential expression of microRNA-210 in gliomas of variable cell origin and correlation between increased expression levels and disease progression in astrocytic tumours. , 2014, Folia neuropathologica.

[54]  Hui Liu,et al.  Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer , 2014, PloS one.

[55]  Xin Huang,et al.  Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response. , 2014, Acta biochimica et biophysica Sinica.

[56]  Z. Zou,et al.  Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis , 2014, PloS one.

[57]  R. Rosenfeld.  Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[58]  M. Ivan,et al.  miR-210: fine-tuning the hypoxic response. , 2014, Advances in experimental medicine and biology.

[59]  Y. Wang,et al.  MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain , 2013, Gene Therapy.

[60]  Tim F. Rayner,et al.  MiR-210 Is Induced by Oct-2, Regulates B Cells, and Inhibits Autoantibody Production , 2013, The Journal of Immunology.

[61]  S. Fucharoen,et al.  Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. , 2013, Blood cells, molecules & diseases.

[62]  K. Pienta,et al.  Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia , 2013, PloS one.

[63]  W. Ding,et al.  Intercellular Communication by Exosome-Derived microRNAs in Cancer , 2013, International journal of molecular sciences.

[64]  Ling Zhou,et al.  WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation. , 2013, Glycobiology.

[65]  J. Kim,et al.  Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2 , 2013, Cell Death and Disease.

[66]  G. Fu,et al.  MicroRNAs in Human Placental Development and Pregnancy Complications , 2013, International journal of molecular sciences.

[67]  J. Ragoussis,et al.  miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis , 2013, British Journal of Cancer.

[68]  Zhigang Wang,et al.  Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma , 2013, Medical Oncology.

[69]  A. Gallo.  RNA editing enters the limelight in cancer , 2013, Nature Medicine.

[70]  Subbaya Subramanian,et al.  MicroRNAs as Biomarkers in Cancer , 2013, Diagnostics.

[71]  W. Xie,et al.  MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes , 2012, Nucleic acids research.

[72]  P. Fasanaro,et al.  Hypoxia-inducible Factor 1-α Induces miR-210 in Normoxic Differentiating Myoblasts* , 2012, The Journal of Biological Chemistry.

[73]  J. Mele,et al.  MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. , 2012, Placenta.

[74]  M. Michael,et al.  Hypoxic enhancement of exosome release by breast cancer cells , 2012, BMC Cancer.

[75]  X. Niu,et al.  miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia , 2012, Molecular and Cellular Biochemistry.

[76]  R. Bast,et al.  Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients , 2012, Cancer.

[77]  Jianping Cao,et al.  Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. , 2012, Experimental cell research.

[78]  N. Kondo,et al.  High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. , 2012, Japanese journal of clinical oncology.

[79]  C. Croce,et al.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.

[80]  Shuhan Sun,et al.  Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease , 2012, Journal of cellular and molecular medicine.

[81]  W. Guo,et al.  Hypoxia‐inducible MicroRNA‐210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma , 2011, Hepatology.

[82]  R. Mutharasan,et al.  microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. , 2011, American journal of physiology. Heart and circulatory physiology.

[83]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[84]  M. Seto,et al.  Overexpression of miR‐210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells , 2011, The Journal of pathology.

[85]  T. Ha.  MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease , 2011, Immune network.

[86]  P. Puigserver,et al.  A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1α Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like , 2011, Molecular and Cellular Biology.

[87]  P Barbry,et al.  miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity , 2011, Cell Death and Differentiation.

[88]  M. Ivan,et al.  miR‐210: More than a silent player in hypoxia , 2011, IUBMB life.

[89]  Maria Kafousi,et al.  MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer , 2011, Cell cycle.

[90]  G. Tsujimoto,et al.  MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)* , 2010, The Journal of Biological Chemistry.

[91]  Leigh-Ann MacFarlane,et al.  MicroRNA: Biogenesis, Function and Role in Cancer , 2010, Current genomics.

[92]  P. Huang,et al.  Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression , 2010, Oncogene.

[93]  R. Gutzmer,et al.  MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma , 2010, International journal of cancer.

[94]  Kai Stühler,et al.  Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas , 2010, Brain pathology.

[95]  Xin Huang,et al.  MiR-210--micromanager of the hypoxia pathway. , 2010, Trends in molecular medicine.

[96]  Borivoj Vojnovic,et al.  MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU , 2010, PloS one.

[97]  Avner Friedman,et al.  Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds , 2010, Proceedings of the National Academy of Sciences.

[98]  H. Taubert,et al.  Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.

[99]  M. Simon,et al.  mir-210: a sensor for hypoxic stress during tumorigenesis. , 2009, Molecular cell.

[100]  Ricky T. Tong,et al.  Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. , 2009, Molecular cell.

[101]  Xudong Dai,et al.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT , 2009, Cell cycle.

[102]  T. Han,et al.  Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. , 2009, American journal of obstetrics and gynecology.

[103]  Robert L Moritz,et al.  Exosomes: proteomic insights and diagnostic potential , 2009, Expert review of proteomics.

[104]  Mircea Ivan,et al.  MicroRNA regulation of DNA repair gene expression in hypoxic stress. , 2009, Cancer research.

[105]  R. Gambari,et al.  Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. , 2009, BMB reports.

[106]  John W M Martens,et al.  Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer , 2008, Proceedings of the National Academy of Sciences.

[107]  N. Kosaka,et al.  Identification of erythropoietin‐induced microRNAs in haematopoietic cells during erythroid differentiation , 2008, British journal of haematology.

[108]  Fabio Martelli,et al.  MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* , 2008, Journal of Biological Chemistry.

[109]  R V Davuluri,et al.  A microRNA component of the hypoxic response , 2008, Cell Death and Differentiation.

[110]  Carme Camps,et al.  hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer , 2008, Clinical Cancer Research.

[111]  B. Weber,et al.  miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer , 2008, Cancer biology & therapy.

[112]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[113]  C. Croce,et al.  miRNAs, Cancer, and Stem Cell Division , 2005, Cell.

[114]  Kristin C. Gunsalus,et al.  microRNA Target Predictions across Seven Drosophila Species and Comparison to Mammalian Targets , 2005, PLoS Comput. Biol..

[115]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.